| CLSI | FDA | EUCAST |
---|
Microorganism | S | I | R | S | I | R | S | I | R |
---|
Enterobacterales | < 4 | 8 | > 16 | < 4 | 8 | > 16 | < 2 | -- | > 2 |
P. aeruginosa | < 4 | 8 | > 16 | < 1 | 2 | > 4 | < 2 | -- | > 2 |
A. baumannii | < 4 | 8 | > 16 | < 1 | 2 | > 4 | NA | NA | NA |
S. maltophilia | < 4 | 8 | > 16 | NA | NA | NA | NA | NA | NA |
- Breakpoint CLSI published in June 2018; update expected in 2021. Breakpoint FDA updated till September 2020. Breakpoint EUCAST published in April 2020
- I intermediate, NA non-applicable, R resistant, S sensible, MIC minimum inhibitory concentration, CLSI Clinical and Laboratory Standards Institute, FDA Food and Drug Administration, EUCAST European Committee on Antimicrobial Susceptibility Testing